SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-054531
Filing Date
2013-07-15
Accepted
2013-07-15 16:35:47
Documents
11
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a13-15405_110q.htm 10-Q 291162
2 EX-31.1 a13-15405_1ex31d1.htm EX-31.1 9936
3 EX-31.2 a13-15405_1ex31d2.htm EX-31.2 9504
4 EX-32.1 a13-15405_1ex32d1.htm EX-32.1 6560
5 EX-32.2 a13-15405_1ex32d2.htm EX-32.2 6163
  Complete submission text file 0001104659-13-054531.txt   2645504

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20130531.xml EX-101.INS 108820
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20130531.xsd EX-101.SCH 42492
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20130531_cal.xml EX-101.CAL 23514
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20130531_lab.xml EX-101.LAB 501684
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20130531_pre.xml EX-101.PRE 242821
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20130531_def.xml EX-101.DEF 130022
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 13968561
SIC: 2835 In Vitro & In Vivo Diagnostic Substances